| Citation: |
CHEN Chen, WU Ying, HUA Xian, LU Jinnan, LI Yi, ZHAO Chunhua, MIN Han. Influence of Host Factors on Drug Resistance of Helicobacter Pylori Infection[J]. Medical Journal of Peking Union Medical College Hospital, 2024, 15(5): 1091-1099. DOI: 10.12290/xhyxzz.2024-0011
|
To analyze the host factors affecting the drug resistance of Helicobacter pylori (Hp).
Patients with Hp infection were consecutively recruited in the Affiliated Suzhou Hospital of Nanjing Medical University from November 2021 to October 2023. Endoscopic biopsy specimens were collected for pathological diagnosis, Hp strain culture and antimicrobial susceptibility test. Nineteen factors involving the basic information, lifestyle, dietary habits, and health status of the patients were collected through electronic medical records and questionnaires. Logistic regression was used to evaluate the association between the patients' factors and drug resistance to clarithromycin, levofloxacin, amoxicillin, furazolidone, tetracycline and metronidazole.
A total of 115 patients (Hp strain 115) with Hp infection who met the inclusion and exclusion criteria were enrolled. There were 53 males (46.09%) and 62 females (53.91%), with an average age of (45.16±13.39) years. Gastroscopic pathology showed 86 cases (74.78%) of superficial gastritis, 6 cases (5.22%) of atrophic gastritis, 14 cases (12.17%) of intestinal metaplasia, 6 cases (5.22%) of low-grade intraepithelial neoplasia, and 3 cases (2.61%) of high-grade intraepithelial neoplasia/gastric cancer. The drug resistance rates of Hp strains to metronidazole, levofloxacin and clarithromycin were 91.30% (105/115), 53.04% (61/115) and 51.30% (59/115), respectively. Resistance to amoxicillin, furazolidone and tetracycline was not found. Dual drug resistance: levofloxacin + metronidazole dual resistance rate was 50.43% (58/115), clarithromycin + metronidazole dual resistance rate was 47.83% (55/115), clarithromycin + levofloxacin dual resistance rate was 36.52% (42/115). Multidrug resistance: clarithromycin + levofloxacin + metronidazole triple resistance rate was 34.78% (40/115). Multivariate Logistic regression analysis showed that (metronidazole was not included in the multivariate analysis due to the absence of sensitive strains), previous Hp eradication history (OR=74.782, 95% CI: 10.377-538.886, P < 0.001) and tap water (OR=4.919, 95% CI: 1.160-20.859, P=0.031) increased the risk of clarithromycin resistance, and age ≥50 years increased the risk of levofloxacin resistance (OR=4.261, 95% CI: 1.420-12.785, P=0.010), previous Hp eradication history (OR=5.855, 95% CI: 2.209-15.517, P < 0.001), 40-59 years old (OR= 3.269, 95% CI: 1.254-8.520, P=0.015) increased the risk of dual resistance to clarithromycin and levofloxacin.
The drug resistance rate of Hp strains isolated from patients in the Affiliated Suzhou Hospital of Nanjing Medical University to metronidazole, levofloxacin and clarithromycin were high, and dual drug resistance and multidrug resistance were prominent. Age, previous Hp eradication history and drinking water source may be associated with single or dual drug resistance to clarithromycin and levofloxacin. Comprehensive consideration, reasonable selection of antibiotics and individualized treatment should be taken into account during Hp eradication.
| [1] |
Rugge M, Genta R M, Di Mario F, et al. Gastric cancer as preventable disease[J]. Clin Gastroenterol Hepatol, 2017, 15(12): 1833-1843. DOI: 10.1016/j.cgh.2017.05.023
|
| [2] |
Kato M, Hayashi Y, Nishida T, et al. Helicobacter pylori eradication prevents secondary gastric cancer in patients with mild-to-moderate atrophic gastritis[J]. J Gastroenterol Hepatol, 2021, 36(8): 2083-2090. DOI: 10.1111/jgh.15396
|
| [3] |
Liou J M, Malfertheiner P, Lee Y C, et al. Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus[J]. Gut, 2020, 69(12): 2093-2112. DOI: 10.1136/gutjnl-2020-322368
|
| [4] |
Hong J B, Shu X, Liu D S, et al. Antibiotic resistance and CYP2C19 polymorphisms affect the efficacy of concomitant therapies for Helicobacter pylori infection: an open-label, randomized, single-centre clinical trial[J]. J Antimicrob Chemother, 2016, 71(8): 2280-2285. DOI: 10.1093/jac/dkw118
|
| [5] |
Yap T W C, Gan H M, Lee Y P, et al. Helicobacter pylori eradication causes perturbation of the human gut microbiome in young adults[J]. PLoS One, 2016, 11(3): e0151893. DOI: 10.1371/journal.pone.0151893
|
| [6] |
Malfertheiner P, Megraud F, Rokkas T, et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report[J]. Gut, 2022, 71(9): 1724-1762. DOI: 10.1136/gutjnl-2022-327745
|
| [7] |
Shah S C, Iyer P G, Moss S F. AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review[J]. Gastroenterology, 2021, 160(5): 1831-1841. DOI: 10.1053/j.gastro.2020.11.059
|
| [8] |
The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 13.1[EB/OL]. [2024-01-05]. http://www.eucast.org.
|
| [9] |
中华医学会病理分会消化病理学组筹备组. 慢性胃炎及上皮性肿瘤胃黏膜活检病理诊断共识[J]. 中华病理学杂志, 2017, 46(5): 289-293.
The Group of Digestive Diseases of Chinese Society of Pathology. Consnesus for diagnostic pathology in biopsies of chronic gastritis and epithelial neoplasms[J]. Chin J Pathol, 2017, 46(5): 289-293.
|
| [10] |
Zhang Y, Feng X Y, Bian L J, et al. Antibiotic resistance of Helicobacter pylori and related risk factors in yangzhou, China: a cross-sectional study[J]. J Clin Med, 2023, 12(3): 816. DOI: 10.3390/jcm12030816
|
| [11] |
Boyanova L, Evstatiev I, Yordanov D, et al. Three unsuccessful treatments of Helicobacter pylori infection by a highly virulent strain with quadruple antibiotic resistance[J]. Folia Microbiol (Praha), 2016, 61(4): 307-310. DOI: 10.1007/s12223-015-0439-2
|
| [12] |
王艳, 周惠琴, 唐文. 苏州市胃肠病患者幽门螺旋杆菌耐药分析[J]. 中国公共卫生杂志, 2010, 26(1): 122-123.
Wang Y, Zhou H Q, Tang W. Helicobacter pylori resistant to antibiotic isolated in Suzhou area[J]. Chin J Public Health, 2010, 26(1): 122-123.
|
| [13] |
Su P, Li Y M, Li H Z, et al. Antibiotic resistance of Helicobacter pylori isolated in the Southeast Coastal Region of China[J]. Helicobacter, 2013, 18(4): 274-279. DOI: 10.1111/hel.12046
|
| [14] |
Lyu T, Cheung K S, Ni L, et al. High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study[J]. J Antimicrob Chemother, 2020, 75(11): 3391-3394. DOI: 10.1093/jac/dkaa315
|
| [15] |
Bluemel B, Goelz H, Goldmann B, et al. Antimicrobial resistance of Helicobacter pylori in Germany, 2015 to 2018[J]. Clin Microbiol Infect, 2020, 26(2): 235-239. DOI: 10.1016/j.cmi.2019.06.007
|
| [16] |
Guo C G, Jiang F, Cheung K S, et al. Timing of prior exposure to antibiotics and failure of Helicobacter pylori eradication: a population-based study[J]. J Antimicrob Chemother, 2022, 77(2): 517-523. DOI: 10.1093/jac/dkab415
|
| [17] |
马小莹, 郑浩, 汪庆庆, 等. 江苏省不同水源抗生素污染及生态风险评估[J]. 环境卫生学杂志, 2020, 10(2): 131-137.
Ma X Y, Zheng H, Wang Q Q, et al. Current status of antibiotic contamination and its ecological risk evaluation in different water bodies of Jiangsu Province[J]. J Environ Hyg, 2020, 10(2): 131-137.
|
| [18] |
Samreen, Ahmad I, Malak H A, et al. Environmental antimicrobial resistance and its drivers: a potential threat to public health[J]. J Glob Antimicrob Resist, 2021, 27: 101-111. DOI: 10.1016/j.jgar.2021.08.001
|
| [19] |
Wang W, Liu F, Baloch Z, et al. Genotypic characterization of methicillin-resistant Staphylococcus aureus isolated from pigs and retail foods in China[J]. Biomed Environ Sci, 2017, 30(8): 570-580.
|
| [20] |
Kim J, Hwang B K, Choi H, et al. Characterization of mcr-1-harboring plasmids from pan drug-resistant Escherichia coli strains isolated from retail raw chicken in South Korea[J]. Microorganisms, 2019, 7(9): 344. DOI: 10.3390/microorganisms7090344
|
| [21] |
Raza S, Choi S, Lee M, et al. Spatial and temporal effects of fish feed on antibiotic resistance in coastal aquaculture farms[J]. Environ Res, 2022, 212(Pt A): 113177.
|
| [22] |
Abbott T, Kor-Bicakci G, Islam M S, et al. A review on the fate of legacy and alternative antimicrobials and their metabolites during wastewater and sludge treatment[J]. Int J Mol Sci, 2020, 21(23): 9241. DOI: 10.3390/ijms21239241
|
| [23] |
梅浩, 赵喆, 赵靖涛, 等. 幽门螺杆菌感染患者耐药的危险因素分析[J]. 胃肠病学, 2022, 27(2): 87-91.
Mei H, Zhao Z, Zhao J T, et al. Analysis of risk factors of drug resistance in patients with Helicobacter pylori infection[J]. Chin J Gastroenterol, 2022, 27(2): 87-91.
|
| [24] |
Li S Y, Li J, Dong X H, et al. The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: a retrospective study over 8 years in Beijing[J]. Helicobacter, 2021, 26(4): e12804. DOI: 10.1111/hel.12804
|
| 1. |
刘敏，杨金苹，赵金颜，乔建红. 老年共病患者自我感知老化、抑郁情绪与生活质量的相关性研究. 心理月刊. 2024(21): 58-60 .
|
Supported by: Beijing Renhe Information Technology Co., Ltd. 
Submit
Review
Office
Email Alert
RSS
DownLoad: